The Indian Institute of Technology (IIT) Madras launched the 'Nilekani Centre at AI4Bharat' to promote the state of Indian language technology with the intention to create a societal impact.
Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
EXAMIANS